These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25956029)

  • 1. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
    Kim JY; Cho YE; Park JH
    Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
    Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
    J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.
    Lee S; Cho YE; Kim SH; Kim YJ; Park JH
    Oncotarget; 2017 Mar; 8(10):16293-16302. PubMed ID: 27323397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.
    Li Z; Hann SR
    Oncogene; 2013 Apr; 32(15):1988-94. PubMed ID: 22665062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun N-terminal kinase regulates the nucleoplasmic translocation and stability of nucleolar GLTSCR2 protein.
    Lee S; Cho YE; Kim YJ; Park JH
    Biochem Biophys Res Commun; 2016 Mar; 472(1):95-100. PubMed ID: 26903295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
    Li Z; Boone D; Hann SR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.
    Lee S; Kim JY; Kim YJ; Seok KO; Kim JH; Chang YJ; Kang HY; Park JH
    Cell Death Differ; 2012 Oct; 19(10):1613-22. PubMed ID: 22522597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Myc-nucleophosmin-ARF network: a complex web unveiled.
    Li Z; Hann SR
    Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
    Di Fiore PP
    J Cell Biol; 2008 Jul; 182(1):7-9. PubMed ID: 18625839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
    Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
    J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
    Yeh CW; Huang SS; Lee RP; Yung BY
    Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small nucleolar RNA SNORA51 enhances breast cancer stem cell-like properties via the RPL3/NPM1/c-MYC pathway.
    Li S; Jin Z; Song X; Ma J; Peng Z; Yu H; Song J; Zhang Y; Sun X; He M; Yu X; Jin F; Zheng A
    Mol Carcinog; 2024 Jun; 63(6):1117-1132. PubMed ID: 38421204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin regulates the stability and transcriptional activity of p53.
    Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
    Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
    Li J; Sejas DP; Burma S; Chen DJ; Pang Q
    Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
    Brodská B; Holoubek A; Otevřelová P; Kuželová K
    J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus.
    Gaviraghi M; Vivori C; Pareja Sanchez Y; Invernizzi F; Cattaneo A; Santoliquido BM; Frenquelli M; Segalla S; Bachi A; Doglioni C; Pelechano V; Cittaro D; Tonon G
    EMBO J; 2018 Dec; 37(23):. PubMed ID: 30373810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription.
    Gurumurthy M; Tan CH; Ng R; Zeiger L; Lau J; Lee J; Dey A; Philp R; Li Q; Lim TM; Price DH; Lane DP; Chao SH
    J Mol Biol; 2008 Apr; 378(2):302-17. PubMed ID: 18371977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.